Evidence map›Paper›PMID 31817839›Full record

ArticleCancers2019

NGF-Enhanced Vasculogenic Properties of Epithelial Ovarian Cancer Cells Is Reduced by Inhibition of the COX-2/PGE

Maritza P Garrido, Iván Hurtado, Manuel Valenzuela-Valderrama, Renato Salvatierra, Andrea Hernández, Margarita Vega, Alberto Selman, Andrew F G Quest, Carmen Romero

Open access · goldAbstract read
In one paragraph

Article in Cancers, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 31 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Ginsenoside 20(S)-Rg3 reducesJournal of ginseng research · 2024
    Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Nerve growth factor orchestrates NGAL and matrix metalloproteinases activity to promote colorectal cancer metastasis.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2022
    Article
  12. Review
  13. Review
  14. Article
  15. NGF/TRKA Decrease miR-145-5p Levels in Epithelial Ovarian Cancer Cells.International journal of molecular sciences · 2020
    Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Maritza P GarridoLaboratorio de Endocrinología y Biología de la Reproducción, Hospital Clínico Universidad de Chile, Santiago 8380456, Chile.
Iván HurtadoLaboratorio de Endocrinología y Biología de la Reproducción, Hospital Clínico Universidad de Chile, Santiago 8380456, Chile.ORCID 0000-0002-9557-6736
Manuel Valenzuela-ValderramaLaboratorio de Microbiología Celular. Instituto de Investigación e Innovación en Salud. Facultad de Ciencias de la Salud, Universidad Central de Chile, Santiago 8320000, Chile.ORCID 0000-0002-8833-7382
Renato SalvatierraLaboratorio de Endocrinología y Biología de la Reproducción, Hospital Clínico Universidad de Chile, Santiago 8380456, Chile.
Andrea HernándezLaboratorio de Endocrinología y Biología de la Reproducción, Hospital Clínico Universidad de Chile, Santiago 8380456, Chile.
Margarita VegaLaboratorio de Endocrinología y Biología de la Reproducción, Hospital Clínico Universidad de Chile, Santiago 8380456, Chile.
Alberto SelmanDepartamento de Obstetricia y Ginecología, Facultad de Medicina, Universidad de Chile, Santiago 8380453, Chile.
Andrew F G QuestAdvanced Center for Chronic Diseases (ACCDIS), Santiago 8380000, Chile.ORCID 0000-0001-8755-1590
Carmen RomeroLaboratorio de Endocrinología y Biología de la Reproducción, Hospital Clínico Universidad de Chile, Santiago 8380456, Chile.
Hospital Clínico de la Universidad de Chile · CLAdvanced Center for Chronic Diseases · CLUniversity of Chile · CL

Funding

Capacity development for HIV and mental health research in Asia (CHIMERA)D43TW011302 · FIC · FOUNDATION FOR AIDS RESEARCH · PI ANNETTE H SOHN, MILTON L WAINBERG · 2019 to 2026
$2.1M
CONICYT-FONDAP # 15130011Fondo Nacional de Desarrollo Científico y Tecnológico #1160139 (CRO); #1130250 and #1170925 (AFGQ)
6 · The paper itself

Abstract

Epithelial ovarian cancer (EOC) is a lethal gynecological neoplasia characterized by extensive angiogenesis and overexpression of nerve growth factor (NGF). Here, we investigated the mechanism by which NGF increases vascular endothelial growth factor (VEGF) expression and the vasculogenic potential of EOC cells, as well as the contribution of the cyclooxygenase 2/prostaglandin E

Indexed as

beta-cateninc-MYCCOX-2/PGE2epithelial ovarian cancerNGFsurvivinvasculogenesisVEGF

Identifiers

PMID31817839
PMCPMC6966471
OpenAlexW2994606095

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.